Correlation between physicochemical characteristics, pharmacokinetic properties and transdermal absorption of NSAID's

International Journal of Pharmaceutics

Volumn 163, Issue 1-2, 1998, Pages 203-209

  Goosen, C ^a   Du Plessis, J ^a   Muller D G ^a   Janse Van Rensburg, L F ^a  

^a NORTH WEST UNIVERSITY   (South Africa)

Author keywords

Absorption; Indomethacin; Ketoprofen; Phar macokinetic; Physicochemical; Piroxicam; Transdermal

Indexed keywords

INDOMETACIN; KETOTIFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; NONHUMAN; PARTITION COEFFICIENT; PREDICTION; PRIORITY JOURNAL; RAT; SKIN PERMEABILITY; SOLUBILITY; STRATUM CORNEUM; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0032542785     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00359-1     Document Type: Article

References (32)

1. Abdou, H.M., 1989. Dissolution, Bioavailability and Bioequivalence. Mack, Easton, Pa, 311 p.
2. Babar A., Solanki U.D., Cutie A.J., Plakogiannis F. Piroxicam release from dermatological bases: in vitro studies using cellulose membrane and hairless mouse skin. Drug Dev. Ind. Pharm. 16:1990;523-540.
3. Beckett, A.H., 1982. Possibilities and limitations of transdermal absorption. In: Aulton, M. (Ed.), Pharmaceutics: The Science of Dosage Form Design. Churchill Livingstone, New York, pp. 154-170.
4. Berba J., Goranson S., Langle J., Banakar U.V. In vitro release of selected nonsteroidal anti-inflammatory analgesics from reservoir type transdermal formulations. Drug Dev. Ind. Pharm. 17:1991;55-65.
5. Chi S.C., Jun H.W. Anti-inflammatory activity of ketoprofen gel on carrageenaminduced paw edema in rats. J. Pharm. Sci. 79:1990;974-977.
6. Fang X.L., Jiang X.G., Zhang Z.R., Xi N.Z. Comparison of concentration of piroxicam in blood and local site after two routes of administration. Acta Pharm Sinica. 30:1995;226-229.
7. Guy, R.H., Hadgraft, J., 1989. Selection of drug candidates for transdermal delivery. In: Hadgraft, J., Guy, R.H. (Eds.), Transdermal Drug Delivery. Developmental Issues and Research Initiatives. Marcel Dekker, New York, pp. 59-81.
8. Guy R.H., Hadgraft J. Transdermal drug delivery: a simplified pharmacokinetic approach. Int. J. Pharm. 24:1985;267-274.
9. Hadgraft, J., Wolff, M., 1993. Physicochemical and pharmacokinetic parameters affecting percutaneous absorption. In: Gurny, R., Teubner, A., Eds., Dermal and Transdermal Drug Delivery. Wissenschaftliche Verlagsgesellschaft, Stuttgart, pp. 161-172.
10. Hansch, C., Leo, A. (Eds.), 1997. Substituent Constants for Correlation Analysis in Chemistry and Biology. Wiley, New York, 292 p.
11. Jack, L., Cameron, B.D., Scott, R.C., Hadgraft, J., 1991. In vitro percutaneous absorption of salicylic acid; effect of vehicle pH. In: Scott, R.C., Guy, R.H., Hadgraft, J., Boddé, H.E. (Eds.), Prediction of Percutaneous Penetration. IBC Technical, London, pp. 515-518.
12. Jacobs J., Golstein A.G., Kelly M.E., Bloom B.S. NSAID dosing schedule and compliance. Drug. Intell Clin Pharm. 22:1988;726-727.
13. Jawién W.A. A method for statistical comparison of bioavailability when only one concentration-time point per individual is available. Int. J. Clin. Pharmacol. Therap. Toxicol. 30:1992;484-485.
14. Jiang X.G., Cui J.B., Xi N.Z. Bioavailability of piroxicam transdermal preparations in human volunteers. Chin Pharm. J. 30:1995;544-547.
15. Lien E.J., Tong G.L. Physicochemical properties and percutaneous absorption of drugs. J. Soc. Cos. Chem. 24:1973;371-384.
16. Lin S.Z., Wouessidjewe D., Poelman M.C., Duchone D. In vivo evaluation of indomethacin/cyclodextrin complexes: gastro-intestinal tolerance and dermal anti-inflammatory activity. Int. J. Pharm. 106:1994;63-67.
17. Liron Z., Cohen S. Percutaneous absorption of alkanoic acids II: application of regular solution theory. J. Pharm. Sci. 73:1984;538-542.
18. Liversidge, G.G., 1981. Ketoprofen. In: Florey, K. (Ed.), Analytical Profiles of Drug Substances, Vol. 10. Academic Press, New York, pp. 443-469.
19. Lu X.H., Zhao Z.K., Su D., Zheng Q., Xu J.L. Effect of azone on skin permeation of indomethacin adhesive patches. J. China Pharm. Univ. 26(6):1995;335-336.
20. Lund, W. (Ed.), 1994. The Pharmaceutical Codex, 12th Edn. The Pharmaceutical Press, London, pp. 908-1010.
21. Marais, M., 1992. The transdermal permeability of water, urea and amino acids: a comparative in vivo - in vitro study. Potchefstroom: PU for CHE (Dissertation - M.Sc.), 143 p.
22. Merck Index, 1989. An Encyclopedia of Chemicals, Drugs and Biologicals, 11th Edn. Merck, Rahway, pp. 786-1192.
23. Mihalic, M., Hofman, H., Kuftinec, J., Krile, B., Caplar, V., Kaiser, F., Blazevic, N., 1986. Piroxicam. In: Florey, K. (Ed.), Analytical Profiles of Drug Substances, Vol. 15. Academic Press, New York, pp. 509-531.
24. Okabe H., Suzuki E., Saitoh T., Takayama K., Nagai T. Development of novel transdermal system containing d-limonene and ethanol as absorption enhancers. J. Control. Rel. 32:1994;243-247.
25. Proudfoot, S.G., 1988. Factors influencing bioavailability: factors influencing drug absorption from the gastrointestinal tract. In: Aulton, M.E. (Ed.), Pharmaceutics: The Science of Dosage Form Design. Churchill Livingstone, New York, pp. 135-173.
26. Ritschel, W.A. (Ed.), 1992. Handbook of Basic Pharmacokinetics, 4th Edn. Drug Intelligence Publications, Hamilton, 588 p.
27. Ritschel, W.A., 1988. Pharmacokinetic and biopharmaceutical aspects in drug delivery. In: Tyle, P., (Ed.), Drug Delivery Devices. Fundamentals and Applications. Marcel Dekker, New York, pp. 17-79.
28. Roth, H.J., Fenner, H., 1988. Pharm. Chemie III, Arzneistoffe, George Thiemie, Stuttgart.
29. Singh S.K., Roane D.S., Reddy I.K., Durrani M.J., Khan M.A. Effect of additives on the diffusion of ketoprofen through human skin. Drug Dev. Ind. Pharm. 22:1996;471-474.
30. Smith, K.L., 1990. Penetrant characteristics influencing skin absorption. In: Kemppainen, B.W., Reifenrath, W.G. (Eds.), Methods for Skin Absorption. CRC Press, Boca Raton, pp. 23-43.
31. Valenta C., Almasi S.I. In vitro diffusion studies of ketoprofen transdermal therapeutic systems. Drug Dev. Ind. Pharm. 21:1995;1799-1805.
32. Yano T., Nakagawa A., Tsuji M., Noda K. Skin permeability of various nonsteroidal anti-inflammatory drugs in man. Life Sciences. 39:1986;1043-1050.